Duraffour S - Search Results

1

Specific targeting of the F13L protein by ST-246 affects orthopoxvirus production differently.

Duraffour S, Vigne S, Vermeire K, Garcel A, Vanstreels E, Daelemans D, Yang G, Jordan R, Hruby DE, Crance JM, Garin D, Andrei G, Snoeck R. Duraffour S, et al. Antivir Ther. 2008;13(8):977-90. Antivir Ther. 2008. PMID: 19195323

2

Epithelial raft cultures for investigations of virus growth, pathogenesis and efficacy of antiviral agents.

Andrei G, Duraffour S, Van den Oord J, Snoeck R. Andrei G, et al. Among authors: duraffour s. Antiviral Res. 2010 Mar;85(3):431-49. doi: 10.1016/j.antiviral.2009.10.019. Epub 2009 Oct 31. Antiviral Res. 2010. PMID: 19883696 Review.

3

Activity of the anti-orthopoxvirus compound ST-246 against vaccinia, cowpox and camelpox viruses in cell monolayers and organotypic raft cultures.

Duraffour S, Snoeck R, de Vos R, van Den Oord JJ, Crance JM, Garin D, Hruby DE, Jordan R, De Clercq E, Andrei G. Duraffour S, et al. Antivir Ther. 2007;12(8):1205-16. Antivir Ther. 2007. PMID: 18240860

4

Specific inhibition of orthopoxvirus replication by a small interfering RNA targeting the D5R gene.

Vigne S, Germi R, Duraffour S, Larrat S, Andrei G, Snoeck R, Garin D, Crance JM. Vigne S, et al. Among authors: duraffour s. Antivir Ther. 2008;13(3):357-68. Antivir Ther. 2008. PMID: 18572748

5

Tecovirimat, a p37 envelope protein inhibitor for the treatment of smallpox infection.

Duraffour S, Andrei G, Snoeck R. Duraffour S, et al. IDrugs. 2010 Mar;13(3):181-91. IDrugs. 2010. PMID: 20191435 Review.

6

Mutations conferring resistance to viral DNA polymerase inhibitors in camelpox virus give different drug-susceptibility profiles in vaccinia virus.

Duraffour S, Andrei G, Topalis D, Krečmerová M, Crance JM, Garin D, Snoeck R. Duraffour S, et al. J Virol. 2012 Jul;86(13):7310-25. doi: 10.1128/JVI.00355-12. Epub 2012 Apr 24. J Virol. 2012. PMID: 22532673 Free PMC article.

7

ST-246 is a key antiviral to inhibit the viral F13L phospholipase, one of the essential proteins for orthopoxvirus wrapping.

Duraffour S, Lorenzo MM, Zöller G, Topalis D, Grosenbach D, Hruby DE, Andrei G, Blasco R, Meyer H, Snoeck R. Duraffour S, et al. J Antimicrob Chemother. 2015 May;70(5):1367-80. doi: 10.1093/jac/dku545. Epub 2015 Jan 27. J Antimicrob Chemother. 2015. PMID: 25630650 Free PMC article.

8

Activities of several classes of acyclic nucleoside phosphonates against camelpox virus replication in different cell culture models.

Duraffour S, Snoeck R, Krecmerová M, van Den Oord J, De Vos R, Holy A, Crance JM, Garin D, De Clercq E, Andrei G. Duraffour S, et al. Antimicrob Agents Chemother. 2007 Dec;51(12):4410-9. doi: 10.1128/AAC.00838-07. Epub 2007 Sep 24. Antimicrob Agents Chemother. 2007. PMID: 17893157 Free PMC article.

9

Inhibition of vaccinia virus replication by two small interfering RNAs targeting B1R and G7L genes and their synergistic combination with cidofovir.

Vigne S, Duraffour S, Andrei G, Snoeck R, Garin D, Crance JM. Vigne S, et al. Among authors: duraffour s. Antimicrob Agents Chemother. 2009 Jun;53(6):2579-88. doi: 10.1128/AAC.01626-08. Epub 2009 Mar 23. Antimicrob Agents Chemother. 2009. PMID: 19307376 Free PMC article.

10

Camelpox virus.

Duraffour S, Meyer H, Andrei G, Snoeck R. Duraffour S, et al. Antiviral Res. 2011 Nov;92(2):167-86. doi: 10.1016/j.antiviral.2011.09.003. Epub 2011 Sep 16. Antiviral Res. 2011. PMID: 21945248 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters